PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40684194,Unveiling the power of plumbagin: revitalizing exhausted T cells to combat tongue cancer.,2025,,"Key Laboratory of Oral Diseases in Jiangxi Province, First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.; Key Laboratory of Oral Diseases in Jiangxi Province, First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.; Key Laboratory of Oral Diseases in Jiangxi Province, First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.; Key Laboratory of Oral Diseases in Jiangxi Province, First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.; Key Laboratory of Oral Diseases in Jiangxi Province, First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. qiujiaxuan@163.com.",qiujiaxuan@163.com.
40680249,Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis.,2025,Matteo Gastaldi; Pietro Businaro; Isabelle Korn-Lubetzki; Johannes Michael; Sabine Rumpler-Kreiner; Florian Schwendinger; Johannes Troger,"Department of Neurology, San Maurizio Provincial Hospital, Bolzano, Italy.",
40677211,Inhibition of NFE2L1 Enables the Tumor-Associated Macrophage Polarization and Enhances Anti-PD1 Immunotherapy in Glioma.,2025,,"Laboratory of Neuroscience, Institute of Cognitive Neuroscience and School of Pharmacy, University College London, London, UK.",
40673010,"A phase 2 study of tislelizumab combined with bevacizumab and chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer.",2025,,"Maternal and Child Health Hospital of Jiangxi Province, Nanchang, PR China.",
